Send us Feedback

IRIS International (IRIS)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
Envista Signs Deal with Google to Utilize and Resell Google Maps Engine
Benzinga  Mar 14  Comment 
IRIS from Envista, a new Platform-as-a-Service (PaaS) that allows the rapid configuration of custom apps for the utility, pipeline and other industries, signed an agreement with Google Inc. (NASDAQ: GOOG) to utilize and resell Google Maps Engine....
Port Huron Hospital to Implement Quantros IRIS Clinical Business Intelligence Platform
Cloud Computing  Dec 18  Comment 
Quantros, a leading provider of quality, safety and clinical business intelligence solutions for the healthcare industry, today announced that Port Huron Hospital has agreed to implement the Quantros IRIS Executive™ clinical...
U.S. Index Leaders and Laggards 09/17: (CVX) (GILD) (IRIS) Up; (CSCO) (VMC) (THLD) Down
StreetInsider.com  Sep 17  Comment 
Dow: Chevron (NYSE: CVX) gained 0.7% Cisco (Nasdaq: CSCO) declined 2% S&P 500: Gilead Sciences (Nasdaq: GILD) gained 5% Vulcan Materials (NYSE: VMC) declined 7% Nasdaq: IRIS Holdings (Nasdaq: IRIS) gained 45% Threshold...
Stocks Hitting 52-Week Highs
Benzinga  Sep 17  Comment 
IRIS International (NASDAQ: IRIS) shares jumped 45.01% to create a new 52-week high of $19.46. Danaher (NYSE: DHR) announced its plans to buy IRIS at a purchase price of $19.50 per share. Gilead Sciences (NASDAQ: GILD) shares gained 4.48% to...
Pre-Open Movers 9/17: (IRIS) (GNOM) (ODP) Higher; (THLD) (LDK) (OREX) Lower (more...)
StreetInsider.com  Sep 17  Comment 
IRIS International Inc. (NASDAQ: IRIS) 45% HIGHER ; Danaher (NYSE: DHR) acquires IRIS International for $19.50/share Threshold Pharmaceuticals (NASDAQ: THLD) 26% LOWER ; to Present Updated Data From Phase 2b Clinical Trial of TH-302 in...
Unusual 11 Mid-Day Movers 09/17: (IRIS) (REGI) (LTRE) Higher; (THLD) (TRGT) (AHS) Lower
StreetInsider.com  Sep 17  Comment 
Benzinga's Top Pre-Market Gainers
Benzinga  Sep 17  Comment 
IRIS International (NASDAQ: IRIS) soared 43.44% to $19.25 in the pre-market trading. Danaher (NYSE: DHR) announced its plans to buy IRIS at a purchase price of $19.50 per share. Complete Genomics (NASDAQ: GNOM) surged 13.86% to $3.04 in the...
Danaher Corporation to Acquire IRIS International for Approximately $338 Million
Benzinga  Sep 17  Comment 
Danaher Corporation (NYSE: DHR) announced today that it has entered into a definitive merger agreement with IRIS International, Inc. (NASDAQ: IRIS) pursuant to which Danaher will acquire IRIS by making a cash tender offer to acquire all of the...
IRIS International Says Will be Acquired by Danaher for $19.50
Benzinga  Sep 17  Comment 
Danaher to buy Iris International for $355 mln
Reuters  Sep 17  Comment 
IRIS to Release Second Quarter Financial Results and Host Conference Call and Webcast on Tuesday, July 31
Globe Newswire  Jul 19  Comment 
CHATSWORTH, Calif., July 19, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables and a provider of high-value personalized diagnostics, today announced that
IRIS International Announces Distribution Agreement With Alifax and Launch of ESR Automated Instrumentation
Globe Newswire  Jul 17  Comment 
CHATSWORTH, Calif., July 17, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables and a provider of high-value personalized diagnostics, today announced the
IRIS International Announces Clinical Data Presentation of NADiA(R) ProsVue(TM) Benefits at the 5th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer
Globe Newswire  Jun 6  Comment 
CHATSWORTH, Calif., June 6, 2012 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables and a provider of high-value personalized diagnostics, today announced that




more ▼WIKI ANALYSIS
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_1/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_1/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_1/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800.
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


 




References

Retrieved from "http://www.wikinvest.com/stock/IRIS_International_(IRIS)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki